Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Neogen Corporation’s common stock is reported as being beneficially owned by Gates Capital Management entities and Jeffrey L. Gates, who together report 8,385,534 shares, or 3.9% of the company’s common stock. All of these shares are shown with shared voting and shared dispositive power, and none with sole authority.
The ownership percentage is calculated using 217,525,981 shares outstanding as of November 30, 2025, as disclosed in Neogen’s Form 10-Q for that period. The reporting parties state that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Neogen.
Neogen Corp’s CEO, Nassif Mikheal, reported an indirect open‑market purchase of company stock associated with his son. On February 17, 2026, 23 shares of Neogen common stock were bought at $10.94 per share. Following this trade, 704 shares are reported as indirectly owned "by son." A footnote states that Mikheal disclaims beneficial ownership of these securities, meaning he does not concede that he is their beneficial owner for regulatory or any other purpose.
Neogen Corporation filed a Form 4 detailing small stock purchases made in an account held by the CEO’s son. On 01/26/2026, the son purchased 25 shares of common stock at $9.855 per share, and on 02/02/2026, 24 shares at $9.9997 per share. After these trades, that account held 681 shares. The filing states that CEO Nassif Mikheal reports these holdings indirectly and expressly disclaims beneficial ownership of these securities.
Neogen Corporation reported that a senior vice president received new equity awards on 01/07/2026. The officer was granted 261,210 stock options with a conversion price of
In addition, the officer acquired 50,813 shares of common stock linked to options and RSUs and another 50,813 shares tied to PSUs, both at a reference price of
Neogen Corporation Senior Vice President Tamara A. Ranalli reported new equity awards. On January 7, 2026, she was granted 130,605 options$7.38 per share, leaving her with 130,605 derivative securities beneficially owned directly. The same day she also acquired 50,813 shares of common stock at a stated price of $7.38 per share, bringing her directly held common stock to 50,813 shares. According to the filing, the options and restricted stock units vest in three equal annual installments on each of the first three anniversaries of the grant date.
Neogen Corporation executive Tamara A. Ranalli filed an initial ownership report as a Senior Vice President of the company. The Form 3 states that no Neogen securities are beneficially owned, meaning she reported holding no direct or indirect shares or derivative securities of the company as of the event date of 01/07/2026.
Neogen Corporation insider reporting shows an indirect purchase of company stock linked to its CEO. On January 16, 2026, an account held by the CEO’s son bought 137 Common Shares of Neogen at $9.3349 per share. After this trade, that account held 632 Common Shares in total. The transaction is reported as indirect ownership "By son", and the reporting person, CEO and director Nassif Mikheal, explicitly disclaims beneficial ownership of these securities.
Neogen Corporation filed a current report to disclose that it has released financial results for its fiscal 2026 second quarter, which ended on November 30, 2025. The company furnished a press release, dated January 8, 2026, as Exhibit 99.1 to provide details about its results of operations and financial condition for this period. The information in this report and the attached press release is being furnished rather than filed, meaning it is not incorporated by reference into other regulatory documents.
Neogen Corp (NEOG) reported an insider transaction on a Form 4. A company insider who is both a Director and CEO reported an open‑market purchase (code P) of 177 common shares at $6.25 on 11/03/2025.
Following this transaction, the filing lists 495 shares beneficially owned, reported as Indirect (I) by son. The filing includes a standard disclaimer that the reporting person disclaims beneficial ownership of these indirectly held securities.